Skip to main content

Main menu

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
      • Local Voices Webinar
      • Connecting Creators and Users of Knowledge
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers

User menu

  • My Alerts

Search

  • Advanced search
Global Health: Science and Practice
  • My Alerts

Global Health: Science and Practice

Dedicated to what works in global health programs

Advanced Search

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Alerts
  • Find GHSP on LinkedIn
  • Visit GHSP on Facebook
  • RSS
ORIGINAL ARTICLE
Open Access

Development and Piloting of Implementation Strategies to Support Delivery of a Clinical Intervention for Postpartum Hemorrhage in Four sub-Saharan Africa Countries

Gillian Forbes, Shahinoor Akter, Suellen Miller, Hadiza Galadanci, Zahida Qureshi, Fadhlun Alwy Al-beity, G. Justus Hofmeyr, Neil Moran, Sue Fawcus, Mandisa Singata-Madliki, Aminu Ado Wakili, Taiwo Gboluwaga Amole, Baba Maiyaki Musa, Faisal Dankishiya, Adamu Abdullahi Atterwahmie, Abubakar Shehu Muhammad, John Ekweani, Emily Nzeribe, Alfred Osoti, George Gwako, Jenipher Okore, Amani Kikula, Emmy Metta, Ard Mwampashi, Cherrie Evans, Kristie-Marie Mammoliti, Adam Devall, Arri Coomarasamy, Ioannis Gallos, Olufemi T. Oladapo, Meghan A. Bohren and Fabiana Lorencatto
Global Health: Science and Practice October 2024, 12(5):e2300387; https://doi.org/10.9745/GHSP-D-23-00387
Gillian Forbes
aCentre for Behaviour Change, University College London, London, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shahinoor Akter
bGender and Women’s Health Unit, Nossal Institute for Global Health, School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suellen Miller
cDepartment of Obstetrics, Gynaecology, and Reproductive Sciences, School of Medicine, University of California, San Francisco, CA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hadiza Galadanci
dAfrica Center of Excellence for Population Health and Policy, Bayero University, Kano, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zahida Qureshi
eDepartment of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fadhlun Alwy Al-beity
fDepartment of Obstetrics and Gynecology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Justus Hofmeyr
gEffective Care Research Unit, University of the Witwatersrand and Walter Sisulu University, Johannesburg, South Africa.
hDepartment of Obstetrics and Gynecology, University of Botswana, Gaborone, Botswana.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Moran
iKwaZulu-Natal Department of Health; and Department of Obstetrics and Gynaecology, School of Clinical Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sue Fawcus
jDepartment of Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mandisa Singata-Madliki
gEffective Care Research Unit, University of the Witwatersrand and Walter Sisulu University, Johannesburg, South Africa.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aminu Ado Wakili
dAfrica Center of Excellence for Population Health and Policy, Bayero University, Kano, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taiwo Gboluwaga Amole
dAfrica Center of Excellence for Population Health and Policy, Bayero University, Kano, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baba Maiyaki Musa
dAfrica Center of Excellence for Population Health and Policy, Bayero University, Kano, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Faisal Dankishiya
dAfrica Center of Excellence for Population Health and Policy, Bayero University, Kano, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adamu Abdullahi Atterwahmie
kFederal Medical Center, Nguru, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abubakar Shehu Muhammad
lAbubakar Tafawa Belawa University Teaching Hospital, Bauch, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Ekweani
mFederal Medical Center, Abuja, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily Nzeribe
nFederal Medical Center, Owerri, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfred Osoti
eDepartment of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Gwako
eDepartment of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenipher Okore
eDepartment of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amani Kikula
fDepartment of Obstetrics and Gynecology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
oDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
pGlobal Health Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmy Metta
qDepartment of Behavioural Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ard Mwampashi
fDepartment of Obstetrics and Gynecology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cherrie Evans
rMaternal and Newborn Health Unit, Technical Leadership and Innovation, Jhpiego, Baltimore, MD, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristie-Marie Mammoliti
sWHO Collaborating Centre on Global Women’s Health, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Devall
sWHO Collaborating Centre on Global Women’s Health, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arri Coomarasamy
sWHO Collaborating Centre on Global Women’s Health, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ioannis Gallos
tUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olufemi T. Oladapo
tUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meghan A. Bohren
bGender and Women’s Health Unit, Nossal Institute for Global Health, School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabiana Lorencatto
aCentre for Behaviour Change, University College London, London, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: f.lorencatto{at}ucl.ac.uk
PreviousNext
  • Article
  • Figures & Tables
  • Supplements
  • Info & Metrics
  • Comments
  • PDF
Loading

Figures & Tables

Figures

  • Tables
  • Additional Files
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    The E-MOTIVE Intervention Early Detection Calibrated Blood Collection Drape With WHO First-Response Treatment Bundle

    Abbreviations: E-MOTIVE, early detection of postpartum hemorrhage using a calibrated drape, massage of uterus, oxytocic drugs administration, tranexamic acid administration, intravenous fluids administration, examination for identifying and managing the source of bleeding, and escalation to more advanced care, if bleeding continues despite treatment; IV, intravenous; PPH, postpartum hemorrhage; TXA, tranexamic acid; WHO, World Health Organization.

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Timeline of E-MOTIVE Research Program

    Abbreviation: E-MOTIVE, early detection of postpartum hemorrhage using a calibrated drape, massage of uterus, oxytocic drugs administration, tranexamic acid administration, intravenous fluids administration, examination for identifying and managing the source of bleeding, and escalation to more advanced care, if bleeding continues despite treatment.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1.

    Overview of Key Findings About Future Uptake of a New Bundled Approach to PPH Detection and Management Across Data Sources and Countries

    KenyaNigeriaSouth AfricaTanzaniaQES
    InterviewsSurveyInterviewsSurveyInterviewsSurveyInterviewsSurvey
    PPH detection
    Use of a new measurement tool such as the calibrated drape will require staff being trained in how to use itAgreeNot foundAgreeNot foundAgreeNot foundNot foundNot foundNot found
    The new measurement tool (calibrated drape) can accurately measure blood loss which consequently could result in more PPH being detectedAgreeNot foundAgreeNot foundAgreeNot foundNot foundNot foundNot found
    Concerns about how the new measurement tool (calibrated drape) will fit in with current methods of collecting bloodAgreeNot foundAgreeNot foundAgreeNot foundNot foundNot foundNot found
    PPH treatment
    All components of the care bundle are part of current PPH management except tranexamic acid which is not routinely administeredAgreePartially AgreeAgreePartially AgreeAgreePartially AgreeNot foundPartially AgreeNot found
    Training on using tranexamic acid is required particularly for midwives who currently may not administer IV medicationsAgreePartially AgreeAgreeAgreeAgreeDisagreeNot foundPartially AgreeNot found
    Use of multiple interventions like in the PPH care bundle depends on having a large team available; one person cannot deliver the care bundleAgreeAgreeNot foundPartially AgreeAgreePartially AgreePartially AgreePartially AgreeNot found
    Future uptake of a care bundle could be effective at changing how PPH is currently treated for vaginal birthsAgreePartially AgreeAgreePartially AgreeAgreePartially AgreeNot foundAgreeNot found
    Overall use of a “bundled” approach to PPH treatment
    Uptake of multiple interventions when treating PPH (e.g., MOTIVE bundle) will be challenging for staff to implement in the futureDisagreePartially AgreeDisagreePartially AgreeDisagreePartially AgreeNot foundPartially AgreeNot found
    The uptake of MOTIVE bundle depends on the confidence of staff to deliver all components as a bundle, i.e., all at once or in quick successionNot foundNot foundPartially AgreeNot foundPartially AgreeNot foundNot foundNot foundNot found
    Uptake of MOTIVE bundle relies on having sufficient staff on wards and having a reliable supply and consistent stock of the necessary drugs and equipmentAgreeAgreeAgreeAgreeAgreeAgreeAgreeAgreeAgree
    The MOTIVE bundle to detect and treat PPH is likely to improve current management of vaginal births and reduce PPH-related mortalityAgreeAgreeAgreeAgreeAgreeAgreeNot foundAgreeNot found
    • Abbreviations: MOTIVE, massage of uterus, oxytocic drugs administration, tranexamic acid administration, intravenous fluids administration, examination for identifying and managing the source of bleeding, and escalation to more advanced care, if bleeding continues despite treatment; PPH, postpartum hemorrhage; QES, qualitative evidence synthesis.

    • View popup
    TABLE 2.

    Mapping of Triangulated Findings Using BCW to Identify Proposed Implementation Strategies for the E-MOTIVE Intervention

    Summary of FindingsCOM-B

    Intervention

    Types From BCW

    Proposed Implementation Strategies for E-MOTIVE Trial Context
    Need for earlier PPH detection from accurate blood loss measurement

    Capability(physical and psychological)

    EducationTrainingEnablement

    Training of new skills to use the calibrated drape: new blood loss collection and measurement tool to prompt and facilitate earlier detection.Training of core or new skills to deliver MOTIVE bundle including simulation practice drills.

    Need for training on using the new calibrated drape
    Uncertainty about administering tranexamic acid when not trained to do so
    Using the intervention brings challenges for staff including new skills and confidence building to deliver intervention as intended
    Need for sufficient staff and adequate stocks of PPH drugs and equipmentOpportunity (social and environmental)

    Environmental restructuringModelingEnablement

    Introduce PPH trolley or carry case to organize PPH drugs and equipment in 1 place accompanied by a checklist detailing the medicines and equipment to be stocked (country and site specific).Team-based training with simulation practice and drills to encourage and enable better coordination, teamwork, and communication when managing a PPH.

    Need for teamwork to implement intervention
    Intervention use will bring about positive changes to PPH treatmentMotivation (reflective)

    EducationPersuasionModelingEnablement

    Introduce audit and feedback to monitor MOTIVE bundle uptake.Introduce a person in leadership role to “champion” the E-MOTIVE intervention implementation.

    Uncertainty about how using the calibrated drape will fit in with current methods for collecting blood
    Perceptions that intervention use can potentially reduce PPH mortality
    • Abbreviations: BCW, Behavior Change Wheel; COM-B, capability, opportunity, motivation-behavior; E-MOTIVE, early detection of PPH using a calibrated drape, followed by massage of uterus, oxytocic drugs administration, tranexamic acid administration, intravenous fluids administration, examination for identifying and managing the source of bleeding, and escalation to more advanced care, if bleeding continues despite treatment; PPH, postpartum hemorrhage.

    • View popup
    TABLE 3.

    Findings From Stakeholder Consultation and Design Workshops and Country-Specific Adaptations

    E-MOTIVE InterventionIntervention/Implementation Strategy SummaryWorkshop FindingsCountry-Specific Adaptations

    PPH detection:Calibrated drape

    A calibrated drape will be tied around the woman’s waist after the baby is born to collect blood loss for the first hour after birth; if bleeding continued beyond the first hour, blood loss will be collected for a second hour.The calibrated drape includes 2 trigger lines at 300 ml and 500 ml of blood loss.Monitor vital signs (blood pressure and pulse rate), do clinical observations (uterine tone and vaginal blood flow) and take readings of calibration lines every 15 minutes and document it in patient notes.

    • Agreement on how to respond when blood loss reaches 300 ml (i.e., be alert to possible PPH) and at 500 ml (i.e., trigger MOTIVE bundle).

    • Calibration lines were perceived as useful. However, some health workers may diagnose a PPH at 300 ml when there are poor vital signs, so did not want to wait until 500 ml to act.

    • Agreement on blood loss being recorded in patient notes every 15 minutes.

    • Vital signs taken every 15 minutes and recorded in patient notes.

    Limited scope to change 300 ml and 500 ml trigger lines because it is fixed by trial protocol.As agreed, what clinical actions should occur at specific volumes of blood loss:For Nigeria, Tanzania, and Kenya, the criteria for triggering the bundle were:

    1. Clinical diagnosis of PPH, as per usual practice.

    2. ≥500 ml blood loss in the drape.

    3. ≥300–500 ml blood loss + an abnormal vital sign or observation.

    • South Africa adopted criteria (1) and (2) above, but not (3).As agreed, develop a blood loss monitoring tool to support reading of calibration line and recording.

    PPH treatment:MOTIVE bundle

    Give all treatments in quick succession described as a “bundled approach” to managing PPH
    • Local protocols do not always allow midwives to administer tranexamic acid. Tranexamic acid is either only given by doctors or by midwives under a doctor’s prescription.

    • At some sites, only doctors would do an internal vaginal examination.

    Limited scope to change the bundle components because it is fixed by WHO recommendations4As needed, adapt existing local protocols so midwives can administer tranexamic acid.Address skillsets in training as required (see E-MOTIVE training below).

    Implementation Strategy
    E-MOTIVE TrainingTraining of on-site trainers provided by Jhpiegoa On-site trainers deliver a facility-based, hands-on approach of training to all nurses, midwives, and doctors working on maternity wards including follow-up (e.g., skills practice simulation drills).
    • Limited consensus on the frequency of initial training of staff by on-site trainer.

    • Concerns about holding follow-up practice simulation drill on a weekly basis, especially at sites where there are few or staff shortages.

    • Merge E-MOTIVE training with Essential Steps in the Managing Obstetric Emergenciesb training to avoid any conflicts about best PPH practice (in South Africa).

    • Adjust frequency of practice simulation drills (n=8) depending on the size of the workforce (in Nigeria, Tanzania).

    • More training on tranexamic acid and internal examination specifically for midwives.

    PPH trolley or carry casePPH trolley or carry case including a content checklist both to be provided by the trial program
    • Agreement about having a PPH trolley in the labor wards. Having a PPH trolley may be too large for some sites, therefore a smaller carry case was preferred.

    • Some sites already have drugs and equipment checklist which could be used instead of an additional checklist which could increase paperwork workload of staff.

    Sites to select the type of PPH kit, e.g., carry case in smaller wards (in Kenya, Nigeria and Tanzania), PPH box/ compartment as part of existing obstetric emergency trolley (in South Africa).

    • Store oxytocin and other PPH drugs requiring cold chain in fridge on labor and delivery ward. Other drugs can be stored in the PPH trolley/carry case.

    • Adapt existing stock checklist and assign to check and restock.

    E-MOTIVE championTwo staff per hospital of different clinical cadres (midwife, doctor) to lead and promote implementation of E-MOTIVE intervention and implementation strategies.
    • Agreement that 2 champions of different clinical roles should be implemented.

    • More clarity on the remit of a champion and how it fits in with other competing duties and if champions should be remunerated.

    • Produce a champion handbook (all countries).

    • Provide a platform for champions to virtually meet to give support and to share successes and challenges.

    • None of the champions will be remunerated (all countries).

    Audit and feedback
    • On-site staff to document drugs used for PPH and stock-outs of PPH drugs.

    • Trial program to share number of vaginal births, number of PPH, % of PPH cases given oxytocin and tranexamic acid using dashboard for use with all on-site staff.

    • Agreement about having audit and feedback.

    • Believed that the draft audit and feedback dashboard was difficult to interpret.

    • All staff on maternity unit to receive feedback.

    Develop a simpler, less detailed format for sites and add preferred comparators (i.e., include all study sites in a country).
    • Abbreviations: E-MOTIVE, early detection of postpartum hemorrhage using a calibrated drape; massage of uterus, oxytocic drugs administration, tranexamic acid administration, intravenous fluids administration, examination for identifying and managing the source of bleeding, and escalation to more advanced care, if bleeding continues despite treatment; PPH, postpartum hemorrhage; WHO, World Health Organization.

    • ↵a Jhpiego is a nonprofit organization for international health affiliated with Johns Hopkins University (https://www.jhpiego.org/).

    • ↵b Essential Steps in the Management of Obstetric Emergencies is a skills and drills program for all maternity staff developed in South Africa.

    • View popup
    TABLE 4.

    Pilot Results by Country

     KenyaNigeriaSouth AfricaTanzaniaTotal
    Vaginal births,a,b no.2,4462,6132,8561,6699,584
    PPH cases,b no.301375512811,269
    Rate of PPH cases (%) 301/2,446 (12.3)375/2,613 (14.4)512/2,856 (17.9)81/1,669 (4.9)1,269/9,584 (13.2)
    Adherence of MOTIVE,b no. (%)187 (62.1)215 (57.3)55 (10.7)65 (80.2)522 (41.1)
        Massage213 (70.8)337 (89.9)278 (54.3)77 (95.1)905 (71.3)
        Oxytocin232 (77.1)336 (89.6)312 (60.9)81 (100)961 (75.7)
        Tranexamic acid218 (72.4)293 (78.1)224 (43.8)c71 (87.7)806 (63.5)
        IV fluids228 (75.7)342 (91.2)304 (59.4)78 (96.3)952 (75.0)
        Examination 213 (70.8)254 (67.7)64 (12.5)69 (85.2)600 (47.3)
    Availability of drugs,d % 
        Oxytocin100100100100100
        Tranexamic acid10098.494.499.698.1
    • Abbreviations: IV, intravenous; MOTIVE; massage of uterus, oxytocic drugs administration, tranexamic acid administration, intravenous fluids administration, examination for identifying and managing the source of bleeding, and escalation to more advanced care, if bleeding continues despite treatment; PPH, postpartum hemorrhage.

    • ↵a Only births with source-verified blood loss data.

    • ↵b From individual woman’s case report form.

    • ↵c There may have been underreporting of tranexamic acid due to confusion about naming; tranexamic acid is known as Cyclokapron in South Africa.

    • ↵d From monthly facility-based case report forms.

    • View popup
    TABLE 5.

    Characteristics of Interview Participants in Pilot Phase Process Evaluation

    CharacteristicsKenya (n=15)Nigeria (n=15)South Africa (n=14)Tanzania (n=14)Total (n=58)
    Gender
     Female8811734
     Male773724
    Profession
     Doctor581317
     Midwife or nurse6591131
     Research nurse30003
     Clinical administrative staff12407
    Overall years of experience
     Less than 1 year30003
     1–4 years502613
     5–9 years656522
     More than 10 years1106320
    • View popup
    TABLE 6.

    Overview of Implementation Outcomes Across Observations, Interviews, Audit of Drug Use and Assessment of Implementation Outcomes

    Implementation OutcomeObservationsa(18 observations of vaginal birth, 7 PPHs)Interviews (n=58)Overall Assessment of Implementation Outcomesb
    Fidelity
    Calibrated drape
    • Time of placing the calibrated drape: After birth and before oxytocin for PPH prevention (n=12/18); before birth with funnel rolled up (n=5/18), (1 calibrated drape in South Africa was placed after birth and after oxytocin for PPH prevention).

    • Who placed the drape: midwife conducting the birth (n=11/18) includes 1 student midwife, E-MOTIVE research midwife (n=7/18). The calibrated drape was placed by the E-MOTIVE research midwife in Kenya n=2/7 and Nigeria n=5/7.

    • Checking of blood loss calibration lines: Read for 14/18 births, although position of drape varied (e.g., hanging over bed or flat on bed).

    • Blood swept into funnel of drape: Kenya (n=2/7), Nigeria (n=7/7), South Africa (n=4/4).

    • Blood swept from under the woman:

      • Kenya (n=2/7 drape removal, n=5/7 not done).

      • Nigeria (n=2/7 after birth, n=2/7 after placenta delivery n=1/7 drape removal, n=2/7 not reported).

      • South Africa (n=1/4 after examination and suturing, n=1/4 after placenta and suturing, n=1/4 drape removal, n=1/4 once without timing).

    • Time in place: Kenya (median: 34 min, range: 8–52 min); Nigeria (median: 63 min, range: 22–94 min); South Africa (median: 65 min, range: 57–74 min).

    • Vital signs measured while drape on: Kenya (n=1/7), Nigeria (n=2/7), South Africa (n=7/7).

    All participants reported always using the calibrated drape to detect PPH.

    (Noted: discrepancy between self-reported and observed practice).

    Use of drape: Medium to high fidelity

    Placing of drape by regular staff not employed by E-MOTIVE:

    Low to medium

    fidelity

    MOTIVE components
    • MOTIVE triggered at: blood loss ≥ 500 ml: n=4/7; ≥300 ml + abnormal clinical signs n=1/7; placenta took 15 minutes to deliver n=1/7; not recorded n=1/7.

    • Time between birth and triggering MOTIVE: median=12 minutes (range 5–30 minutes).

    • Administering of MOTIVE components:

      • Massage n=7/7.

      • Oxytocin infusion n=7/7.

      • Other uterotonics (misoprostol n=4/7).

      • Tranexamic acid n=7/7.

      • IV fluid n=7/7.

    • Facility-based CRFs (% increase in brackets: difference between baseline and pilot).c

    • Use of oxytocin (%).

    • Kenya 83%, (+14%); Nigeria 95%, (+30%); South Africa 80%, (+33%); Tanzania 100%, (0%).

    • Overall increase, 34%.

    • Use of tranexamic acid.

    • Kenya 83%, (+47%); Nigeria 90%, (+86%); South Africa 68% (+43%); Tanzania 100%, (+50%).

    • Overall increase, 59%.

    • All participants said, they administered all MOTIVE components of the bundle in quick succession to manage PPH.

    • Participants said, they did not wait to see if one treatment worked before giving another treatment.

    Use of MOTIVE:

    High fidelity

    Training
    • Dedicated space for skills sessions and PPH simulation.

    • 22 simulations took place across countries.

    • Staff (typically nurses and midwives) participated in 2–7 simulation sessions.

    • Across all countries, all participants reported receiving initial training by an on-site trainer.

    • There were mixed responses about attending follow-up skills sessions and PPH simulation.

    • Across all countries some participants said they have not taken part in any practice drill sessions (n=19).

    Initial training: High fidelityFollow-up skills sessions and PPH simulation:Low to mediumfidelity

    PPH trolley/carry case

    • PPH trolley taken to bedside n=1/7.

    • All sites had an accessible PPH trolley which was checked either daily, weekly, or at beginning/end of shift and regularly restocked.

    • Most likely checked by an E-MOTIVE research midwife instead of on-site staff.

    • Substantial variation in the supplies kept in the PPH trolley especially in Kenya and Nigeria.

    • CRADLE devices (to take vital signs) supplied by E-MOTIVE project were often missing.

    • All countries kept oxytocin in fridges (as per local protocol).

    All participants said there was a PPH trolley available on the labor ward; however, some participants said it was not always used.

    Availability of trolley:High fidelityUse of trolley:Low fidelity

    ChampionsNANumber of participants reporting champions at site and number of champions in situ (if known) were:
    • Kenya (n=13); 1–3 champions/sites (doctors and nurses).

    • Nigeria (n=12); 2 champions/site (doctors and nurses).

    • South Africa (n=9): 1–2 champions /site (doctors and nurses).

    • Tanzania (n=10); 1–2 champions/site (doctors and nurses).

    Champions in place:High fidelity

    Audit and feedbackNA
    • Participants, who were aware of audit and feedback (n=12/58).

    • Not all participants were receiving audit/feedback (n=8/58); none in South Africa.

    • Participants reported, consultants and doctors are more likely to receive feedback (n=5/58): in Nigeria and South Africa.

    • Format is verbal and/or graphs (n=5), in Kenya and Tanzania.

    • E-MOTIVE staff (i.e., research midwife, champion, or on-site trainer) deliver audit/feedback to staff (n=5) in Kenya and Tanzania.

    Engagement with audit and feedback:Low fidelity

    Acceptability
    Calibrated Drape and MOTIVE componentsNAAcross all countries, participants were satisfied with using the calibrated drape to detect PPH and using the MOTIVE components to treat PPH.High acceptability
    Training, PPH trolley/carry case, champions and audit and feedbackNAAcross all countries, participants said the implementation strategies offered appropriate support and encouragement to improve uptake of the E-MOTIVE intervention and implementation strategies at their site.High acceptability
    Feasibility
    E-MOTIVE Intervention and implementation strategiesPractical use of the E-MOTIVE intervention, attending the training by nursing staff and using PPH trolley/carry case was demonstrated at all sites.Across all countries, participants reported it was feasible to deliver the bundle and engage with the implementation strategies.High feasibility
    • Abbreviations: CRF, case report form; NA, not assessed via observations; E-MOTIVE, early detection of postpartum hemorrhage, massage of uterus, oxytocic drugs administration, tranexamic acid administration, intravenous fluids administration, examination for identifying and managing the source of bleeding, and escalation to more advanced care, if bleeding continues despite treatment; PPH, postpartum hemorrhage.

    • ↵a No observation completed in Tanzania (fidelity of E-MOTIVE intervention use).

    • ↵b Assessment of implementation outcomes (fidelity, feasibility, acceptability) criteria: low=≤50%; medium=between 51%–79% and high ≥80%.

    • ↵c Data collected by University of Birmingham clinical trial team.

Additional Files

  • Figures
  • Tables
  • Supplemental material

    • Supplements -

      Supplements

PreviousNext
Back to top

In this issue

Global Health: Science and Practice: 12 (5)
Global Health: Science and Practice
Vol. 12, No. 5
October 29, 2024
  • Table of Contents
  • About the Cover
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Global Health: Science and Practice.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Development and Piloting of Implementation Strategies to Support Delivery of a Clinical Intervention for Postpartum Hemorrhage in Four sub-Saharan Africa Countries
(Your Name) has forwarded a page to you from Global Health: Science and Practice
(Your Name) thought you would like to see this page from the Global Health: Science and Practice web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Development and Piloting of Implementation Strategies to Support Delivery of a Clinical Intervention for Postpartum Hemorrhage in Four sub-Saharan Africa Countries
Gillian Forbes, Shahinoor Akter, Suellen Miller, Hadiza Galadanci, Zahida Qureshi, Fadhlun Alwy Al-beity, G. Justus Hofmeyr, Neil Moran, Sue Fawcus, Mandisa Singata-Madliki, Aminu Ado Wakili, Taiwo Gboluwaga Amole, Baba Maiyaki Musa, Faisal Dankishiya, Adamu Abdullahi Atterwahmie, Abubakar Shehu Muhammad, John Ekweani, Emily Nzeribe, Alfred Osoti, George Gwako, Jenipher Okore, Amani Kikula, Emmy Metta, Ard Mwampashi, Cherrie Evans, Kristie-Marie Mammoliti, Adam Devall, Arri Coomarasamy, Ioannis Gallos, Olufemi T. Oladapo, Meghan A. Bohren, Fabiana Lorencatto
Global Health: Science and Practice Oct 2024, 12 (5) e2300387; DOI: 10.9745/GHSP-D-23-00387

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Development and Piloting of Implementation Strategies to Support Delivery of a Clinical Intervention for Postpartum Hemorrhage in Four sub-Saharan Africa Countries
Gillian Forbes, Shahinoor Akter, Suellen Miller, Hadiza Galadanci, Zahida Qureshi, Fadhlun Alwy Al-beity, G. Justus Hofmeyr, Neil Moran, Sue Fawcus, Mandisa Singata-Madliki, Aminu Ado Wakili, Taiwo Gboluwaga Amole, Baba Maiyaki Musa, Faisal Dankishiya, Adamu Abdullahi Atterwahmie, Abubakar Shehu Muhammad, John Ekweani, Emily Nzeribe, Alfred Osoti, George Gwako, Jenipher Okore, Amani Kikula, Emmy Metta, Ard Mwampashi, Cherrie Evans, Kristie-Marie Mammoliti, Adam Devall, Arri Coomarasamy, Ioannis Gallos, Olufemi T. Oladapo, Meghan A. Bohren, Fabiana Lorencatto
Global Health: Science and Practice Oct 2024, 12 (5) e2300387; DOI: 10.9745/GHSP-D-23-00387
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Statistics from Altmetric.com

Jump to section

  • Article
    • ABSTRACT
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Funding
    • Disclaimer
    • Author contributions
    • Competing interests
    • Notes
    • REFERENCES
  • Figures & Tables
  • Supplements
  • Info & Metrics
  • Comments
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Patterns and Drivers of Packaged (Fortified) Maize Flour Purchase in Urban and Peri-Urban Kenya
  • Exploring a Road Map to Achieving Tobacco Endgame in sub-Saharan Africa: A Qualitative Study Among Stakeholders From 12 Countries
  • Stakeholder Perceptions on Innovative Private Pharmacy Distribution Channels and Implications for Medicine Quality in Zambia: A Qualitative Study
Show more ORIGINAL ARTICLE

Similar Articles

Subjects

  • Health Topics
    • Maternal, Newborn, and Child Health
Johns Hopkins Center for Communication Programs

Follow Us On

  • LinkedIn
  • Facebook
  • RSS

Articles

  • Current Issue
  • Advance Access Articles
  • Past Issues
  • Topic Collections
  • Most Read Articles
  • Supplements

More Information

  • Submit a Paper
  • Instructions for Authors
  • Instructions for Reviewers

About

  • About GHSP
  • Advisory Board
  • FAQs
  • Privacy Policy
  • Contact Us

© 2026 Creative Commons Attribution 4.0 International License. ISSN: 2169-575X

Powered by HighWire